Greenwich Wealth Management LLC

Position in PRME — Prime Medicine, Inc.

CIK 1439805 GREENWICH, CT

Position in PRME

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,833,923

+$223,920 QoQ

Shares Held

768,001

+2.4% QoQ

Ownership

0.423%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#27

of 186 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Greenwich Wealth Management LLC holds $13,031,117 across 5 Biotechnology names. PRME ranks #2 (21.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	16,094	$10,035,252
2	PRME	Prime Medicine, Inc. This page	768,001	$2,833,923
3	ANVS	Annovis Bio, Inc.	48,400	$90,024
4	AGEN	Agenus Inc	12,000	$36,720
5	INO	Inovio Pharmaceuticals, Inc.	31,999	$35,198

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,833,923	768,001	+2.4%	Shares	Sole	2026-08-12
2026-03-31	$2,610,003	750,001	+1.4%	Shares	Sole	2026-05-12
2025-12-31	$2,567,803	740,001	+2.8%	Shares	Sole	2026-02-10
2025-09-30	$3,988,805	720,001	-14.9%	Shares	Sole	2025-11-12
2025-06-30	$2,090,116	846,201	+3.3%	Shares	Sole	2025-08-13
2025-03-31	$1,629,811	819,001	+5.8%	Shares	Sole	2025-05-12
2024-12-31	$2,260,082	774,001	+5.6%	Shares	Sole	2025-02-10
2024-09-30	$2,836,713	733,001	+12.3%	Shares	Sole	2024-10-29
2024-06-30	$3,356,425	653,001	+13.0%	Shares	Sole	2024-08-09
2024-03-31	$4,046,007	578,001	+12.7%	Shares	Sole	2024-05-13
2023-12-31	$4,545,188	513,001	+16.9%	Shares	Sole	2024-02-01
2023-09-30	$4,188,260	439,021	+111.1%	Shares	Sole	2023-11-07
2023-06-30	$3,047,200	208,000	-40.4%	Shares	Sole	2023-07-31
2023-03-31	$4,292,700	349,000	—	Shares	Sole	2023-04-24
No filing history on record for this holder in this stock.